Viral vectored hepatitis C virus vaccines generate pan-genotypic T cell responses to conserved subdominant epitopes
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Health Research
- Medical Research Council
- NIHR Oxford Biomedical Research Centre
This publication has 45 references indexed in Scilit:
- HCV epidemiology in high-risk groups and the risk of reinfectionJournal of Hepatology, 2016
- Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antiviralsJournal of Hepatology, 2016
- The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments.BMC Medicine, 2015
- Detection of a Sexually Transmitted Hepatitis C Virus Protease Inhibitor-Resistance Variant in a Human Immunodeficiency Virus–Infected Homosexual ManGastroenterology, 2014
- HCV direct‐acting antiviral agents: the best interferon‐free combinationsLiver International, 2013
- High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infectionGastroenterology, 2004
- Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus InfectionJournal of Experimental Medicine, 2001
- CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustainedEuropean Journal of Immunology, 2000
- Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis CGastroenterology, 1999
- Analysis of a Successful Immune Response against Hepatitis C VirusImmunity, 1999